Hui-Ying Liu

I am an Assistant Professor and attending urologist at Kaohsiung Chang-Gung Memorial Hospital, with a primary focus on urologic oncology and male infertility. After earning my M.D. from Kaohsiung Medical University, I completed my residency training in urology and later pursued further specialization in male reproductive medicine at Taipei Veterans General Hospital. I also had the opportunity to gain international experience through observerships in urologic oncology and robotic surgery in University of Washington Medical Center and Swedish Medical Center. Currently, I am pursuing my Ph.D. at Chang-Gung University, with ongoing research centered on urothelial carcinoma. I am actively involved in academic organizations, serving as Deputy Secretary-General of the Taiwan Urological Oncology Association and the Taiwanese Association for Andrology and Sexual Medicine. People often describe me as energetic, passionate, and positive. I am deeply committed to patient care, education, and research, and I strive to bring that same energy into every aspect of my work. I hope to contribute to the advancement of urology through innovation, collaboration, and compassionate care.

15th August 2025

Time Session
12:00
13:00
Luncheon Symposium 9【PUSEN, QUANTA】
Mastering Suction Ureteroscopy: How the Right Laser and Scope Combination Makes the Difference
TICC - 3F Banquet Hall
13:30
15:00
Young Leadership Forum
Effective Communication Conflict Resolution; Develop a Compelling Vision to Motivate Others
  • Effective Communication Conflict Resolution; Develop a Compelling Vision to Motivate Others
  • Welcome Remarks
    Eddie ChanHong Kong, China Speaker How to Escape Surgical ComplicationsSurgical complications can significantly impact patient outcomes and healthcare resources. This talk will focus on practical strategies to minimize complications in urologic surgery, tailored specifically for urology fellows. Real-life case examples will illustrate how thoughtful preparation and proactive communication can prevent or mitigate complications. Additionally, we will discuss structured approaches to managing complications when they arise, including communication with the patient and team, documentation, and timely intervention. Through real-life case examples, this session aims to enhance surgical judgment, promote patient safety, and build confidence in complication management.
    Jacob See-Tong PangTaiwan Speaker
    Michael WongSingapore Speaker Introduction to Asia School of UrologyAsian School of Urology 2022-2026 – New initiatives Dr Michael YC Wong Principal Director of ASU 2022-2026 President Endourological Society and WCET 2026 Introduction Asian School of Urology (ASU) officially started in 1999 with the appointment of her first director Prof Pichai Bunyaratavej from Thailand (1999-2002) Subsequent directors were Dato Dr Rohan Malek from Malaysia (2002-2006) Prof Foo Keong Tatt from Singapore (2006-2010) Prof Rainy Umbas from Indonesia (2010-2014 ) and Prof Shin Egawa from Japan ( 2014-2022 ). One of the highlights of the ASU in the early days were the organization of several workshops outside of UAA congress by three active sub-specialty sections of UAA namely Asian society of Endourology (over 16 workshops held from 1998-2008), Asian Society of Female Urology and Asia-Pacific society of Uro-Oncology. Other subspecialty sections were subsequently introduced and have matured very well including Asian Society of UTI and STI, Asian-Pacific Society of Andrological and Reconstructive Urology Surgeons. In the last 8 years, ASU has seen tremendous growth under the steady leadership of Prof Shin Egawa with introduction of UAA lecturers at national Meetings and further maturation of the subspecialty sections of UAA e.g., Conversion of Asian society of endourology to Asian Robotic Urological Society to reflect the growth and development of UAA. During the past 8 years, ASU-South-East Asia section has also managed to organize 15 physical workshops and 4 webinars outside of UAA congress. The Growth Trajectory for the next 4 years 2022-2026 There are many areas where ASU can grow further. Bearing in mind our limited resources and our excellent relationships with the world urological leaders at this point in our history. There are three areas which I will focus on. Please remember that ASU is always open to other new initiatives as we must stay relevant to our Asian urological community. 1. Lasting and strong Relationships 1.1 AUA. Over a dish of chili crab with AUA secretary general Gopal Badlani, we explored the common desire to elevate Asian Urology and strengthen UAA Family. This led to our first joint UAA-AUA residency course at UAA Singapore 2016. After successful completion, a MOU was signed at AUA 2017 with Richard Babayan, Manoj Monga, Allen Chiu and myself in attendance. The AURC at UAA Hong Kong under Prof Eddie Chan was the result of this signed MOU. We are extremely grateful for the generosity of AUA for this program. What may not be obvious is that Gopal Badlani, Manoj Monga, John Denstedt and I served as faculty and board directors at WCE. We will sign the extension MOU in 2023 for another three years. 1.2 EAU. We have a very successful UAA-EAU Youth program since UAA Thailand 2012. This has been the work of several UAA senior members. From 2023, we are exploring joint webinars with EAU to build on this relationship. 1.3 SIU and WCE. We will further explore options based on available resources and manpower. Joint Webinar are planned for early 2026 2. Education Platform for Asian Urology Residents From 2023, we will continue to grow our relationship with BJUI. BJUI has developed a world class online learning platform with tremendous investments since 2013. This platform is called BJUI Knowledge. ASU will reach out to all Asian residents via their national urological association president and secretary to encourage every resident to sign up for a free access to more than 420 interactive 30-minute modules covering the whole urology syllabus suitable for learning, exit exams and recertification exams. I am personally involved in developing all modules under Endourology and urolithiasis Section and have been associate editor since May 2013. The modest aim is for at least 10 residents per country to sign up by UAA 2023. We will report progress at each UAA council meeting. Pls see attached information and if there are any questions pls email me personally at email@drmichaelwong.com 3. Re-Strategize Training cum fellowship sites for ASU. 3.1 In the past we have always talked about the possibility about training sites for UAA and ASU. It has always been a difficult task due to financial and multiple logistics issues. 3.2 What can we do that is possible? Let us consider two options in the next 4 years. 3.3 For the last 6 years a group of Asian urologists started AUGTEG to design and provide two-day surgical training which includes lectures as well as dry and wet lab to develop surgical skills. AUSTEG has direct access to physical training centres in Thailand, South Korea, and China. ASU will work with AUGTEC to pool resources since we are the same people working on both sides e.g., Anthony Ng (chairman of AUSTEG) Michael Wong (vice chairman) Eddie Chan (treasurer). AUGTEG is registered in HK. 3.4 The second option is to recognise elected university or training Asian centres to allow an attachment for young urologist post residency in a flexible format. ASU will recognise officially these sites as endorsed by UAA. At UAA 2025 , several potential ASU/UAA fellowship sites directors will be presenting their programmes to kickstart this initiative 4. In conclusion, ASU will continue to grow and serve the Asian Urological Community. The above initiatives are only the beginning of a next chapter. Can you contribute your ideas and current available resources for this purpose? If you can, Pls email me personally at email@drmichaelwong.com Which Position is the Best for PCNL in 2025?With tremendous advances in both technique and technology , the MIS approach to staghorn calculi has evolved significantly over the last 30 years. It is timely to review all the landmark articles on patient positioning as this ultimately determines renal access which in turn plays a major role in stone free rates. We will gain much insight as we debate and attempt to answer the question of which position is best in 2026!
  • Introduction to Young Leadership 2025
    Hung-Jen WangTaiwan Speaker Technical Pearls: Nerve-SparingPreserving the neurovascular bundles (NVB) during robotic-assisted radical prostatectomy (RARP) is crucial for maintaining postoperative continence and sexual function, while still ensuring complete cancer removal. We will share "technical pearls" for nerve-sparing in RARP, emphasizing practical innovations that enhance surgical precision without compromising oncologic control. Retrograde nerve-sparing involves a bottom-up (apex-to-base) dissection of the NVB using an athermal, gentle approach. This technique, adapted from open surgery, allows early identification and release of the nerves under direct vision. By minimizing traction and avoiding cautery near the NVB, it reduces inadvertent nerve injury and even lowers the risk of positive margins at the prostatic base. Clinically, adopting a retrograde approach (often with 30° lens “toggling”) has been linked to faster functional recovery of potency, contributing to potency rates approaching 90% at 1 year in fully nerve-sparing cases. Parallel advances in augmented reality (AR) are providing real-time surgical navigation. AR technology superimposes 3D virtual models (e.g. from MRI) onto the operative field, enhancing visualization of patient-specific anatomy. Surgeons can pinpoint tumor location relative to the NVB, enabling selective, confidence-guided nerve preservation even in locally advanced disease. This approach helps modulate nerve-sparing extent on a case-by-case basis, maintaining oncologic safety (low positive surgical margin rates) while maximizing nerve preservation. Finally, refined anatomical landmarks have emerged to guide nerve-sparing. A notable example is the identification of a consistent small arterial branch (“landmark artery”) at the NVB’s medial aspect. This vessel serves as a guide for partial nerve-sparing: dissecting just lateral to it yields an approximate 3 mm tissue margin from the prostatic capsule, sufficient to clear potential extracapsular extension while preserving the remaining nerve fibers. Such landmark-oriented dissection provides a reproducible framework for tailoring nerve-sparing to tumor risk, moving beyond the traditional “all-or-none” approach. These advanced techniques and concepts are empowering robotic surgeons to achieve optimal outcomes. By integrating retrograde nerve-sparing, AR-assisted navigation, and anatomical landmark guidance, one can improve early continence recovery and postoperative sexual function for patients without sacrificing cancer control.
    Juan Luis VásquezDenmark Speaker Leadership with a Growth MindsetPersonal Path to Excellence in Bladder Cancer
  • Introduction to Asia School of Urology
    Michael WongSingapore Speaker Introduction to Asia School of UrologyAsian School of Urology 2022-2026 – New initiatives Dr Michael YC Wong Principal Director of ASU 2022-2026 President Endourological Society and WCET 2026 Introduction Asian School of Urology (ASU) officially started in 1999 with the appointment of her first director Prof Pichai Bunyaratavej from Thailand (1999-2002) Subsequent directors were Dato Dr Rohan Malek from Malaysia (2002-2006) Prof Foo Keong Tatt from Singapore (2006-2010) Prof Rainy Umbas from Indonesia (2010-2014 ) and Prof Shin Egawa from Japan ( 2014-2022 ). One of the highlights of the ASU in the early days were the organization of several workshops outside of UAA congress by three active sub-specialty sections of UAA namely Asian society of Endourology (over 16 workshops held from 1998-2008), Asian Society of Female Urology and Asia-Pacific society of Uro-Oncology. Other subspecialty sections were subsequently introduced and have matured very well including Asian Society of UTI and STI, Asian-Pacific Society of Andrological and Reconstructive Urology Surgeons. In the last 8 years, ASU has seen tremendous growth under the steady leadership of Prof Shin Egawa with introduction of UAA lecturers at national Meetings and further maturation of the subspecialty sections of UAA e.g., Conversion of Asian society of endourology to Asian Robotic Urological Society to reflect the growth and development of UAA. During the past 8 years, ASU-South-East Asia section has also managed to organize 15 physical workshops and 4 webinars outside of UAA congress. The Growth Trajectory for the next 4 years 2022-2026 There are many areas where ASU can grow further. Bearing in mind our limited resources and our excellent relationships with the world urological leaders at this point in our history. There are three areas which I will focus on. Please remember that ASU is always open to other new initiatives as we must stay relevant to our Asian urological community. 1. Lasting and strong Relationships 1.1 AUA. Over a dish of chili crab with AUA secretary general Gopal Badlani, we explored the common desire to elevate Asian Urology and strengthen UAA Family. This led to our first joint UAA-AUA residency course at UAA Singapore 2016. After successful completion, a MOU was signed at AUA 2017 with Richard Babayan, Manoj Monga, Allen Chiu and myself in attendance. The AURC at UAA Hong Kong under Prof Eddie Chan was the result of this signed MOU. We are extremely grateful for the generosity of AUA for this program. What may not be obvious is that Gopal Badlani, Manoj Monga, John Denstedt and I served as faculty and board directors at WCE. We will sign the extension MOU in 2023 for another three years. 1.2 EAU. We have a very successful UAA-EAU Youth program since UAA Thailand 2012. This has been the work of several UAA senior members. From 2023, we are exploring joint webinars with EAU to build on this relationship. 1.3 SIU and WCE. We will further explore options based on available resources and manpower. Joint Webinar are planned for early 2026 2. Education Platform for Asian Urology Residents From 2023, we will continue to grow our relationship with BJUI. BJUI has developed a world class online learning platform with tremendous investments since 2013. This platform is called BJUI Knowledge. ASU will reach out to all Asian residents via their national urological association president and secretary to encourage every resident to sign up for a free access to more than 420 interactive 30-minute modules covering the whole urology syllabus suitable for learning, exit exams and recertification exams. I am personally involved in developing all modules under Endourology and urolithiasis Section and have been associate editor since May 2013. The modest aim is for at least 10 residents per country to sign up by UAA 2023. We will report progress at each UAA council meeting. Pls see attached information and if there are any questions pls email me personally at email@drmichaelwong.com 3. Re-Strategize Training cum fellowship sites for ASU. 3.1 In the past we have always talked about the possibility about training sites for UAA and ASU. It has always been a difficult task due to financial and multiple logistics issues. 3.2 What can we do that is possible? Let us consider two options in the next 4 years. 3.3 For the last 6 years a group of Asian urologists started AUGTEG to design and provide two-day surgical training which includes lectures as well as dry and wet lab to develop surgical skills. AUSTEG has direct access to physical training centres in Thailand, South Korea, and China. ASU will work with AUGTEC to pool resources since we are the same people working on both sides e.g., Anthony Ng (chairman of AUSTEG) Michael Wong (vice chairman) Eddie Chan (treasurer). AUGTEG is registered in HK. 3.4 The second option is to recognise elected university or training Asian centres to allow an attachment for young urologist post residency in a flexible format. ASU will recognise officially these sites as endorsed by UAA. At UAA 2025 , several potential ASU/UAA fellowship sites directors will be presenting their programmes to kickstart this initiative 4. In conclusion, ASU will continue to grow and serve the Asian Urological Community. The above initiatives are only the beginning of a next chapter. Can you contribute your ideas and current available resources for this purpose? If you can, Pls email me personally at email@drmichaelwong.com Which Position is the Best for PCNL in 2025?With tremendous advances in both technique and technology , the MIS approach to staghorn calculi has evolved significantly over the last 30 years. It is timely to review all the landmark articles on patient positioning as this ultimately determines renal access which in turn plays a major role in stone free rates. We will gain much insight as we debate and attempt to answer the question of which position is best in 2026!
  • To Publish or not to Publish?
    Jeremy TeohHong Kong, China Speaker Transurethral En Bloc Resection of Bladder Tumor: Where Are We Now?There is increasing evidence that transurethral en bloc resection of bladder tumour (ERBT) could lead to better peri-operative and oncological outcomes in patients with non-muscle-invasive bladder cancer. Modified approaches of ERBT have also been proposed to expand its indications for larger bladder tumours. The quality of resection is also the key for bladder-sparing treatment for muscle-invasive bladder cancer. We foresee an exciting journey ahead for ERBT, and as a urologist, we must embrace this novel technique for the best interest of our bladder cancer patients. To Publish or not to Publish? Navigating the path to academia in urologyDoing good science is the basis for technological advancement in healthcare. However, pursuing a path to academic in urology is often tough, stressful and frustrating. In this talk, I will share with you what I have learnt throughout my 15 years of research work. I will let you know what's the best and fastest way to become a globally renowned and successful researcher. Most importantly, I will explain what it takes to develop a great team and create a positive impact in people's lives. Believe in yourself! If I can do it, so can you.SIU Lecture: Role of MISTs in Male LUTS Surgical Management (Will TUR-P/ Laser Prostatectomy be Replaced?)Transurethral resection of prostate (TURP) is the current gold standard in treating patients with benign prostatic hyperplasia. Laser prostatectomy has also been used widely especially in patients who are on anticoagulants. However, both TURP and laser prostatectomy are associated with several problems including the need of spinal / general anaesthesia and the risk of male sexual dysfunction. In the past decade, we have witnessed the introduction of multiple new technologies including Rezum, Urolift, iTind and Aquablation. in this SIU lecture, we will discuss about the technical details, as well as the pros and cons of every new technology. We will also invite you to be our jury and decide whether TURP and laser prostatectomy will be replaced in the future. Novel Intravesical Therapeutics in the Evolving Landscape of NMIBCNon-muscle-invasive bladder cancer (NMIBC) is well known to be a difficult disease to manage, with a 1-year recurrence rate of up to 61% and 5-year recurrence rate of 78%. Despite the use of intravesical BCG therapy, NMIBC patients may still experience recurrence and develop what we call BCG-unresponsive NMIBC. Conventionally, we offer upfront radical cystectomy for patients with BCG-unresponsive NMIBC, however, this is an ultra-major surgery with significant risk of complications and could also lead to significant deterioration in quality of life in the long run. We are in urgent need for novel therapies to manage this difficult condition. In this lecture, we will discuss the evidence on the different novel intravesical therapies in treating BCG-unresponsive NMIBC. SIU Lecture: Role of MISTs in Male LUTS Surgical Management (Will TUR-P/ Laser Prostatectomy be Replaced?)
  • Bringing Innovation to Patient
    Henry HoSingapore Speaker Technical Pearls: Wheel-Barrow TechniquesBringing Innovation to PatientRobotic Partial Nephrectomy: Beyond Technique
  • Road to Excellent Research
    Yao-Chi ChuangTaiwan Speaker Road to Excellent ResearchYao Chi Chuang, Professor of Urology, Kaohsiung Chang Gung Memorial Hospital, and National Sun Yat-sen University Taiwan. Medical research is what allows doctors to explore unmet medical need and decide how to best treat patients. It is what makes the development of new diagnostic tools, new biomarkers, new medicines, and new procedures. Without medical research, we would not be able to creative new knowledge and decide if new treatments are better than our current treatments. There are some Tips on what to do about what research is and how to get into it: 1. Ask a good question from your daily practice, what is unmet medical need? 2. Search the old literature of your research interests- what is known? What is unknown? 3. Find a new method to solve your question or an old method but applying to a new field. 4. Start from jointing a pre-planned research project, and join a research collaborative. 5. Try to be an independent researcher from a small project without funding support, retrospective study. 6. Try to get funding support from your institute, national grant, or industry. As a young doctor, it’s important to look after yourself and maintain a healthy balance between daily practice and research work. There is a range of options for doctors interested in research, from smaller time commitments as a co-investigator to longer-term projects and experience as chief investigator. Research works are all optional activities, so do what you can but don’t overwhelm yourself. Road to Excellent Research
  • How to Escape Surgical Complications
    Eddie ChanHong Kong, China Speaker How to Escape Surgical ComplicationsSurgical complications can significantly impact patient outcomes and healthcare resources. This talk will focus on practical strategies to minimize complications in urologic surgery, tailored specifically for urology fellows. Real-life case examples will illustrate how thoughtful preparation and proactive communication can prevent or mitigate complications. Additionally, we will discuss structured approaches to managing complications when they arise, including communication with the patient and team, documentation, and timely intervention. Through real-life case examples, this session aims to enhance surgical judgment, promote patient safety, and build confidence in complication management.
  • Coffee Break
TICC - 3F Banquet Hall
15:30
17:00
Young Leadership Forum
Meet the Future: Urology Fellowship Opportunities
  • Introduction
    Eddie ChanHong Kong, China Speaker How to Escape Surgical ComplicationsSurgical complications can significantly impact patient outcomes and healthcare resources. This talk will focus on practical strategies to minimize complications in urologic surgery, tailored specifically for urology fellows. Real-life case examples will illustrate how thoughtful preparation and proactive communication can prevent or mitigate complications. Additionally, we will discuss structured approaches to managing complications when they arise, including communication with the patient and team, documentation, and timely intervention. Through real-life case examples, this session aims to enhance surgical judgment, promote patient safety, and build confidence in complication management.
  • Institute Presentation I
    Chi-Hang YeeHong Kong, China Speaker Robotic Total Intracorporeal Urinary Diversion – from Ileal Conduit to Neobladder to Ileal Interposition Prostate Cancer Focal Therapy: Ready for Prime Time?
  • Institute Presentation II
    Kenneth ChenSingapore Speaker Debate: PIRADS 4/5 Negative Biopsies Should
  • Institute Presentation III
    Hung-Jen WangTaiwan Speaker Technical Pearls: Nerve-SparingPreserving the neurovascular bundles (NVB) during robotic-assisted radical prostatectomy (RARP) is crucial for maintaining postoperative continence and sexual function, while still ensuring complete cancer removal. We will share "technical pearls" for nerve-sparing in RARP, emphasizing practical innovations that enhance surgical precision without compromising oncologic control. Retrograde nerve-sparing involves a bottom-up (apex-to-base) dissection of the NVB using an athermal, gentle approach. This technique, adapted from open surgery, allows early identification and release of the nerves under direct vision. By minimizing traction and avoiding cautery near the NVB, it reduces inadvertent nerve injury and even lowers the risk of positive margins at the prostatic base. Clinically, adopting a retrograde approach (often with 30° lens “toggling”) has been linked to faster functional recovery of potency, contributing to potency rates approaching 90% at 1 year in fully nerve-sparing cases. Parallel advances in augmented reality (AR) are providing real-time surgical navigation. AR technology superimposes 3D virtual models (e.g. from MRI) onto the operative field, enhancing visualization of patient-specific anatomy. Surgeons can pinpoint tumor location relative to the NVB, enabling selective, confidence-guided nerve preservation even in locally advanced disease. This approach helps modulate nerve-sparing extent on a case-by-case basis, maintaining oncologic safety (low positive surgical margin rates) while maximizing nerve preservation. Finally, refined anatomical landmarks have emerged to guide nerve-sparing. A notable example is the identification of a consistent small arterial branch (“landmark artery”) at the NVB’s medial aspect. This vessel serves as a guide for partial nerve-sparing: dissecting just lateral to it yields an approximate 3 mm tissue margin from the prostatic capsule, sufficient to clear potential extracapsular extension while preserving the remaining nerve fibers. Such landmark-oriented dissection provides a reproducible framework for tailoring nerve-sparing to tumor risk, moving beyond the traditional “all-or-none” approach. These advanced techniques and concepts are empowering robotic surgeons to achieve optimal outcomes. By integrating retrograde nerve-sparing, AR-assisted navigation, and anatomical landmark guidance, one can improve early continence recovery and postoperative sexual function for patients without sacrificing cancer control.
  • Small Group Discussion
TICC - 3F Banquet Hall

16th August 2025

Time Session
10:30
12:00
Robotic
Robotic Surgery
  • Robotic Surgery
    Jian-Ri LiTaiwan Moderator Applying Vision Augmentation in Robotic Surgery: Reality or FictionApplying Vision Augmentation in Robotic Surgery: Reality or Fiction
    KoonHo RhaKorea (Republic of) Moderator Trend in Healthcare AI
    Pai-Fu WangTaiwan Moderator
  • How to Standardize Training by AI-Learning from The Best Practice of Urological Robotic Surgery
    Ketan BadaniUnited States Speaker Expanding horizons: SP for complex RAPNThe Future of Urological Robotic SurgerySingle-Port Robotic Partial Nephrectomy for Multiple or Large Renal TumorsHow to Standardize Training by AI-Learning from The Best Practice of Urological Robotic SurgerySP Partial Nephrectomy
  • Discussion
  • Complex Robotic Assisted Surgery for Urinary Fistula Repair
    Allen W. ChiuTaiwan Speaker Reflecting on the Past, Shaping the Present, and Envisioning the Future of UAASince 1990, the Urological Association of Asia (UAA) has stood as a beacon of collaboration, innovation, and advancement in urology in Asia. As we reflect on its evolution, acknowledge its current impact, and envision its future, it becomes clear that the UAA has played - and will continue to play - a pivotal role in shaping urological care, education, and research throughout Asia. Reflecting on the path we’ve traveled together from 16 member associations and 1,000 individual members in 2014 to 28 member associations and over 4,500 individual members today - I see more than growth. I see unity, commitment, and a shared belief in something bigger than ourselves. A defining milestone was enrolling the Urological Society of Australia and New Zealand into the UAA, further enriching our diversity and strengthening our position as a truly Asia-Pacific organization. The UAA proudly supports several journals, including the International Journal of Urology, the Indian Journal of Urology, Asian Urology, which continue to shape the academic discourse. The Asian Urological Resident Course (AURC) started in 2014, in collaboration with the American Urological Association, has become a cornerstone in nurturing clinical excellence among young urologists. The Young Leadership Forum, since 2012, developed in partnership with the European Urological Association, has fostered cross-continental mentorship and exchange. These initiatives symbolize our commitment to creating a future shared across borders. We have faced challenges under the impact of COVID-19, but conquered it with resilience and shared purpose. As healthcare needs evolve and patient expectations rise, the UAA aims to: 1. Promote regional research 2. Enhance training and education 3. Strengthen partnerships 4. Champion equity in healthcare.Complex Robotic Assisted Surgery for Urinary Fistula RepairRobotic-assisted (da Vinci) surgery is increasingly used for repair of urinary fistulas, including vesicovaginal, ureterovaginal, and enterovesical fistula. It offers a minimally invasive alternative to open surgery. A case report described using the da Vinci X system to fix a vesicovaginal fistula (VVF) post-hysterectomy in 105 min with no complications, a 2 day hospital stay, and excellent patient reported quality-of-life at 12 months. A literature review including 30 cases showed robotic repair of VVF reduced blood loss and shortened hospital stays by 2 days compared to open repair. A review found that robotic repair of complex urinary fistulas is technically feasible in expert hands, with good early outcomes and less morbidity than open techniques. This presentation illustrated the key operative procedures, inlcuding ureteral catheter placement to identify the ureteral tract, anchoring stitches on opened urinary bladder wall, robotic excision of the fistula tract, layered closure of bladder wall and adjacent organ (vagina or colon), with or without Interposition of tissue flaps (e.g. omentum or peritoneal flaps) to reinforce repair. The robot provides precise and secure ileal isolation with ICG technique for the ileal isolation, and and intracorporeal anastomosis to ureter and urinary bladder are safe. Intracorporeal bowel re-anastomosis and accessibility of the da Vinci platform is becoming more popular. The isolated ileal technique provides good urinary reconstruction (e.g., Neobladder, Augmentation Cystoplasty Ileal conduit (Bricker’s procedure), Orthotopic neobladder (Studer, Hautmann, etc.) The Role of the robot to harvestest, detubularize, and fold ileum to form bladder substitute. Suture to urethra and ureters. It is often performed entirely intracorporeally with the da Vinci Xi system.
  • Discussion
  • Pros and Cons in the daVinci SP System Applications in Urological Surgeries
    Steven L. ChangUnited States Speaker The Progression Landscape of Diagnostic and Treatment Options for Kidney CancerPros and Cons in the daVinci SP System Applications in Urological Surgeries
  • Discussion
TICC - 2F 201DE
13:30
15:00
Young Leadership Forum
  • Leadership with a Growth Mindset
    Juan Luis VásquezDenmark Speaker Leadership with a Growth MindsetPersonal Path to Excellence in Bladder Cancer
  • How to Be a Good Mentor?
    Fabian StanglSwitzerland Speaker How to Be a Good Mentor?Mentorship is one of the most powerful tools for shaping future leaders in urology—but being a good mentor requires more than clinical experience. In this talk, I will explore the essential qualities of effective mentorship, from active listening and goal setting to creating a safe environment for growth and feedback. Drawing on personal experience and successful mentorship models within the EAU and beyond, I will share practical strategies for building meaningful mentor-mentee relationships, supporting diverse career paths, and fostering a culture of mutual learning. Good mentors don’t just teach—they inspire.Why be an EAU Member? Education Opportunities in EuropeThe European Association of Urology (EAU) is more than just a professional society—it is a global platform that empowers urologists at every stage of their career. In this talk, I will highlight the key benefits of EAU membership with a focus on the extensive educational opportunities it offers, particularly for young urologists. From hands-on training, online courses, and fellowships to mentorship programmes and academic collaborations, the EAU provides access to world-class resources that foster clinical excellence and academic growth. I will also share practical examples of how young leaders can connect, learn, and thrive through the EAU network—and why now is the best time to become an active member.
  • Personal Path to Excellence in Bladder Cancer
    Juan Luis VásquezDenmark Speaker Leadership with a Growth MindsetPersonal Path to Excellence in Bladder Cancer
  • Why be an EAU Member? Education Opportunities in Europe
    Fabian StanglSwitzerland Speaker How to Be a Good Mentor?Mentorship is one of the most powerful tools for shaping future leaders in urology—but being a good mentor requires more than clinical experience. In this talk, I will explore the essential qualities of effective mentorship, from active listening and goal setting to creating a safe environment for growth and feedback. Drawing on personal experience and successful mentorship models within the EAU and beyond, I will share practical strategies for building meaningful mentor-mentee relationships, supporting diverse career paths, and fostering a culture of mutual learning. Good mentors don’t just teach—they inspire.Why be an EAU Member? Education Opportunities in EuropeThe European Association of Urology (EAU) is more than just a professional society—it is a global platform that empowers urologists at every stage of their career. In this talk, I will highlight the key benefits of EAU membership with a focus on the extensive educational opportunities it offers, particularly for young urologists. From hands-on training, online courses, and fellowships to mentorship programmes and academic collaborations, the EAU provides access to world-class resources that foster clinical excellence and academic growth. I will also share practical examples of how young leaders can connect, learn, and thrive through the EAU network—and why now is the best time to become an active member.
  • Q & A
  • Coffee Break
TICC - 3F Banquet Hall
15:30
17:00
Young Leadership Forum
Meet the Future: Urology Fellowship Opportunities
TICC - 3F Banquet Hall

17th August 2025

Time Session
08:30
10:00
Plenary Session 5
  • UAA Honorary Member Lecture: Learning through Giving Expert Opinion, a Hong Kong Case Book
    Teng-Aik OngMalaysia Moderator
    Chi Wai ManHong Kong, China Speaker UAA Honorary Member Lecture: Learning through Giving Expert Opinion, a Hong Kong Case BookLearning through giving expert opinion, a Hong Kong urology case book Dr Man, Chi Wai MBBS HK FRCS Edin FRCS Glas FCSHK FHKAM Dip Urol Lond LLB Beij Consultant Urologist, Tuen Mun Hospital In Hong Kong older urologists are often asked to give expert opinions to various parties including the Coroner and the Medical Council. The expert must give unbiased assistance to the justice system. I also try to explain that there are factors other than the urologist care to account for the outcome, and to look for possible improvements in our care. Thanks for allowing me to share with you my humble experience. The Coroner in HK has the duty to determine the cause of death. If the cause is mishap, civil or disciplinary action will follow. I need to explain why death was not preventable when that was the case. The Medical Council is the statutory body responsible for overseeing professional registration and discipline. It carries out inquiries into complaints of misconduct against doctors. Most of these were about unfavourable outcome and disregard of professional responsibilities. Medical Council actively collects evidence required for proof of medical negligence. Defence could be made by disproving damage or causation of damage. In most cases, proof of no breach of duty by focusing on standard of care is required. I need to explain in such cases that despite appropriate and proper care, an unfavourable outcome could still occur. While the Bolam principle still applies to most aspects of patient care, it is no longer the case in warning patients of risks since the Montgomery case. The most important lesson I learned was that good contemporaneous documentation in medical records is the most important line of defence for urologists.
  • Normothermic Ex Vivo Kidney Perfusion for Urologic Discovery
    Shomik SenguptaAustralia Moderator Moderator N/A
    Marshall StollerUnited States Speaker Normothermic Ex Vivo Kidney Perfusion for Urologic Discovery
  • Trend in Healthcare AI
    Atsuko FujiharaJapan Moderator
    KoonHo RhaKorea (Republic of) Speaker Trend in Healthcare AI
  • Bridging AI Frontiers and Urology: How Multimodal and Agentic AI Will Shape 2025
    Pai-Fu WangTaiwan Moderator
    Chung-You TsaiTaiwan Speaker Bridging AI Frontiers and Urology: How Multimodal and Agentic AI Will Shape 20251. **Evolution of AI: From LLM to Agentic AI** AI has progressed rapidly from basic language models (LLMs) to multimodal and agentic systems capable of autonomous decision-making and task execution. 2. **General vs. Domain-Specific LLMs** General-purpose LLMs offer versatility, while domain-specific LLMs (e.g., medical models) provide higher accuracy in specialized fields like urology. 3. **AI Applications in Medical Practice** LLMs and AI agents assist in research, academic writing, and clinical decision-making—transforming how urologists access and apply medical knowledge. 4. **Agentic AI & Multi-Agent Systems** AI agents can orchestrate tools, reason through complex problems, and automate workflows without human input—enhancing productivity in healthcare. 5. **Benchmarking AI vs. Human Experts** In prostate cancer risk assessment, top-tier LLMs demonstrated competitive or superior performance compared to human experts, indicating clinical potential. How to Make AI as the Most Powerful Assistance for the Treatment of GU Cancer?
  • Applying Vision Augmentation in Robotic Surgery: Reality or Fiction
    Rajeev KumarIndia Moderator Troubleshooting in Endoscopic Stone Surgery: How to Handle Unexpected Challenges in RIRS and ECIRSProstate Cancer Nomograms and Their Application in Asian MenNomograms help to predict outcomes in individual patients rather than whole populations and are an important part of evaluation and treatment decision making. Various nomograms have been developed in malignancies to predict and prognosticate clinical outcomes such as severity of disease, overall survival, and recurrence-free survival. In prostate cancer, nomograms were developed for determining need for biopsy, disease course, need for adjuvant therapy, and outcomes. Most of these predictive nomograms were based on Caucasian populations. Prostate cancer is significantly affected by race, and Asian men have a significantly different racial and genetic susceptibility compared to Caucasians, raising the concern about the generalizability of these nomograms. There are very few studies that have evaluated the applicability and validity of the existing nomograms in in Asian men. Most have found significant differences in the performance in this population. Thus, relying on such nomograms for treating Asian men may not be appropriate and collaborative efforts are required within Asian countries to develop locally relevant nomograms.What Is Critical Appraisal?Critical appraisal is the process of systematically evaluating research studies to assess their validity, relevance, and trustworthiness. The goal is to determine whether a study’s results are credible and useful for clinical decision-making, research, or policy. This has become increasingly important as there has been a massive increase in the number of scientific journals and not all published research is of equal quality. Critical appraisal helps healthcare professionals avoid being misled by poor-quality studies, make evidence-based decisions and improve patient outcomes. The key purposes are to assess validity of the study and its results and determine applicability to the specific population. It involves assessing the study design, methodological quality, completeness of reporting, potential sources of bias and potential for misconduct. There are number of reporting guidelines that can be used for performing critical appraisal. Additionally, being aware of essential reporting standards and common problems with studies can help readers make informed decisions.Scientific Misconduct and PitfallsNo abstractExample of the “Ideal” AbstractNo Abstract
    Jian-Ri LiTaiwan Speaker Applying Vision Augmentation in Robotic Surgery: Reality or FictionApplying Vision Augmentation in Robotic Surgery: Reality or Fiction
  • Big Data in Urol Science Research: from Scratch to Hatch
    Noor Ashani Md YusoffMalaysia Moderator Technical Pearls: Node Dissection in Robotic CystectomyHighlight and Limitation in Urology Service in MalaysiaRobotic Pelvic LN Dissection: A critical Component of Bladder Cancer Surgery
    Yao-Chou TsaiTaiwan Speaker Big Data in Urol Science Research: from Scratch to Hatch
TICC - 3F Plenary Hall
10:30
12:00
Andrology 2
Innovations in Male Infertility and Reproductive Health
  • Emerging Therapies, Diagnostics, and Technology in Male Reproductive Health
    Hyun Jun Park Korea (Republic of) Moderator The Evolutionary Role of Varicocelectomy in Andrology Varicocelectomy is among the most commonly performed surgical procedures in contemporary andrological practice. Historically, varicocele management focused primarily on alleviating symptomatic discomfort and addressing infertility characterized by impaired semen parameters. However, the conceptual framework and indications for varicocelectomy have evolved significantly over recent decades, reshaping its clinical implications and expanding its therapeutic potential. Initially, open surgical approaches such as retroperitoneal and inguinal varicocelectomy were predominant, yet they carried considerable risks, including recurrence, hydrocele formation, and potential damage to testicular arteries. With the advent of microsurgical techniques, particularly subinguinal microsurgical varicocelectomy, procedural efficacy and safety have markedly improved. This has resulted in reduced complication rates and enhanced fertility outcomes, positioning microsurgical varicocelectomy as the current gold standard. Modern andrological literature emphasizes varicocelectomy’s broader physiological benefits beyond fertility. Recent studies highlight its role in improving testosterone production, mitigating hypogonadism, and enhancing overall testicular function. Additionally, varicocelectomy has been demonstrated to significantly improve sperm DNA integrity and reduce oxidative stress levels, thus positively impacting assisted reproductive technology (ART) outcomes. Furthermore, contemporary research suggests that varicocelectomy may provide systemic health benefits by reducing chronic inflammation and oxidative damage, conditions associated with metabolic and cardiovascular disorders. This evolving understanding positions varicocelectomy not merely as a fertility treatment but as an integral part of comprehensive male reproductive health management. These insights prompt a proactive approach, encouraging clinicians to recognize varicocelectomy’s extended potential in enhancing male reproductive longevity and general health. In conclusion, the evolution of varicocelectomy, characterized by advancements in surgical techniques and expanded clinical indications, underscores its significant role in modern andrology. An integrated appreciation of its multifaceted therapeutic benefits facilitates informed clinical decision-making, ultimately enhancing patient care and outcomes in andrological practice.
    Chih-Wei TsaoTaiwan Moderator
  • Recent Advances in Fertility Preservation for Young Male Cancer Survivors
    Hui-Ying LiuTaiwan Speaker Recent Advances in Fertility Preservation for Young Male Cancer SurvivorsTesticular cancer (TC) is the most common malignancy in men of reproductive age and significantly impacts fertility through both direct tumor effects and subsequent gonadotoxic treatments. Tumor-related factors such as testicular parenchymal destruction, intratesticular obstruction, elevated β-HCG levels, oxidative stress, and disruption of the hypothalamic–pituitary–gonadal axis contribute to impaired spermatogenesis and sperm DNA fragmentation. Cancer treatments including orchiectomy, chemotherapy (especially cisplatin-based regimens), retroperitoneal lymph node dissection, and radiotherapy further increase the risk of oligo- or azoospermia, with long-term recovery of spermatogenesis often taking up to 2–4 years. Despite these risks, less than one-third of patients undergo sperm cryopreservation before treatment, even though up to 50% present with abnormal semen parameters at diagnosis. Onco-TESE and electroejaculation serve as viable alternatives in select patients, while emerging evidence supports the use of testis-sparing strategies and real-time sperm retrieval in appropriate cases. Current data emphasize the necessity of early fertility counseling and preservation planning for all men diagnosed with TC. Given the high cure rate and young patient demographic, optimizing reproductive outcomes is a key component of survivorship care.
  • Chronic Pelvic Pain Syndrome (CPPS): New Insights and Therapeutic Approaches
    So InamuraJapan Speaker Chronic Pelvic Pain Syndrome (CPPS): New Insights and Therapeutic Approaches Chronic Pelvic Pain Syndrome (CP/CPPS) is a complex condition characterized by a combination of pelvic pain or discomfort and lower urinary tract symptoms (LUTS), including both storage and voiding issues. The pathophysiology is multifaceted, often originating from prostatic inflammation which contributes to both LUTS and pelvic pain. The condition is frequently exacerbated by the involvement of neurogenic inflammation and central sensitization, which can cause pain to spread and amplify, creating a negative spiral of symptoms that significantly impairs patients' quality of life (QOL). This presentation reviews the current understanding of CP/CPPS pathophysiology and outlines therapeutic options. In general, treatment primarily relies on conventional drug therapies such as α1 blockers, anti-inflammatory agents, neuropathic medications, phosphodiesterase 5 inhibitors (PDE5 inhibitors), and phytotherapeutics. These treatments aim to manage symptoms by improving bladder outlet obstruction (BOO), suppressing inflammation, enhancing pelvic blood flow, and modulating pain signals. While various treatment options exist, their effectiveness varies significantly among individuals, underscoring the need for a patient and individualized approach to find a suitable regimen. Furthermore, emerging treatments such as Extracorporeal Shockwave Therapy (ESWT) have shown significant promise in improving pain and QOL and are recommended in international guidelines. In conclusion, effective management of CP/CPPS requires consideration of its complex mechanisms, including prostatic inflammation, neurogenic inflammation, and central sensitization. A patient, trial-and-error approach is essential to identify the most effective treatment for each individual.
  • The Evolutionary Role of Varicocelectomy in Andrology
    Hyun Jun Park Korea (Republic of) Speaker The Evolutionary Role of Varicocelectomy in Andrology Varicocelectomy is among the most commonly performed surgical procedures in contemporary andrological practice. Historically, varicocele management focused primarily on alleviating symptomatic discomfort and addressing infertility characterized by impaired semen parameters. However, the conceptual framework and indications for varicocelectomy have evolved significantly over recent decades, reshaping its clinical implications and expanding its therapeutic potential. Initially, open surgical approaches such as retroperitoneal and inguinal varicocelectomy were predominant, yet they carried considerable risks, including recurrence, hydrocele formation, and potential damage to testicular arteries. With the advent of microsurgical techniques, particularly subinguinal microsurgical varicocelectomy, procedural efficacy and safety have markedly improved. This has resulted in reduced complication rates and enhanced fertility outcomes, positioning microsurgical varicocelectomy as the current gold standard. Modern andrological literature emphasizes varicocelectomy’s broader physiological benefits beyond fertility. Recent studies highlight its role in improving testosterone production, mitigating hypogonadism, and enhancing overall testicular function. Additionally, varicocelectomy has been demonstrated to significantly improve sperm DNA integrity and reduce oxidative stress levels, thus positively impacting assisted reproductive technology (ART) outcomes. Furthermore, contemporary research suggests that varicocelectomy may provide systemic health benefits by reducing chronic inflammation and oxidative damage, conditions associated with metabolic and cardiovascular disorders. This evolving understanding positions varicocelectomy not merely as a fertility treatment but as an integral part of comprehensive male reproductive health management. These insights prompt a proactive approach, encouraging clinicians to recognize varicocelectomy’s extended potential in enhancing male reproductive longevity and general health. In conclusion, the evolution of varicocelectomy, characterized by advancements in surgical techniques and expanded clinical indications, underscores its significant role in modern andrology. An integrated appreciation of its multifaceted therapeutic benefits facilitates informed clinical decision-making, ultimately enhancing patient care and outcomes in andrological practice.
  • New Horizons in Clinical Predictors for Sperm Retrieval in Non-Obstructive Azoospermia Patients
    I-Shen HuangTaiwan Speaker New Horizons in Clinical Predictors for Sperm Retrieval in Non-Obstructive Azoospermia Patients
  • DNA Fragmentation’s Impact on Male Infertility: Advanced molecular approaches in male infertility diagnosis
    Yu-Sheng ChengTaiwan Speaker DNA Fragmentation’s Impact on Male Infertility: Advanced molecular approaches in male infertility diagnosis Semen analysis remains the cornerstone to accessing male fertility potential despite many drawbacks and fails to predict the male fertility potential with high sensitivity and specificity. The integrity of sperm DNA is crucial for successful fertilization, embryo growth, and the precise transmission of genetic information to progeny. Increasing research suggests that higher sperm DNA fragmentation (SDF) may correlate with clinical varicocele, unexplained infertility, recurrent pregnancy loss, and offspring health. Currently, several tests are available to assess sperm DNA fragmentation in clinical settings. The degree of sperm DNA damage can be measured using the sperm DNA fragmentation index (DFI), which provides more insight into the quality of sperm. Recently, several laboratories have integrated SDF testing into routine semen analysis for the assessment of male infertility. Nonetheless, several aspects of SDF remain unresolved. This presentation will provide an introduction to existing SDF assays, including recent innovative tests for double-strand breaks (DSBs) in human ejaculated sperm, as well as a discussion on the clinical indications for SDF testing based on recent scientific findings.
  • The Role of Artificial Intelligence in Male Infertility: Innovations in Diagnosis and Treatment Optimization
    Vincent FS TsaiTaiwan Speaker The Role of Artificial Intelligence in Male Infertility: Innovations in Diagnosis and Treatment Optimization Artificial Intelligence (AI) is reshaping the landscape of reproductive medicine by offering unprecedented precision, personalization, and predictive power. This presentation introduces some current AI-integrated fertility projects, designed to enhance outcomes across both pre- and post-fertilization stages. We begin with a brief overview of AI’s transformative role in healthcare, before delving into the scope. In the pre-fertilization phase, we leverage AI tools for semen analysis, enabling rapid and objective assessment of sperm quality---a home semen test. Advanced image recognition aids in tissue classification, while robotic precision enhances microsurgical interventions. Additionally, machine learning algorithms provide nuanced risk prediction to support clinical decision-making. Post-fertilization, some systems apply AI-driven models for embryo selection and manipulation, optimizing implantation potential. Predictive analytics further extend to embryonic development, offering clinicians early insights that support successful pregnancies. Together, these innovations illustrate how AI can augment every stage of the fertility journey—offering not only efficiency but also a hopeful future for prospective parents.
TICC - 2F 201DE
TUA Video Award (Mandarin)
TICC - 1F 101B